Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.11
0.000.00%
At close: -
$1.09
-0.02-1.80%
After Hours: 7:56 PM EDT
Comments
Loading...
ImmunoPrecise Antibodies Analyst Ratings and Price Targets | NASDAQ:IPA | Benzinga
ImmunoPrecise Antibodies Ltd has a consensus price target of $4 based on the ratings of 2 analysts. The high is $5 issued by HC Wainwright & Co. on April 11, 2025. The low is $3 issued by Benchmark on April 1, 2025. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Benchmark, and HC Wainwright & Co. on April 11, 2025, April 1, 2025, and March 31, 2025, respectively. With an average price target of $4.33 between HC Wainwright & Co., Benchmark, and HC Wainwright & Co., there's an implied 297.55% upside for ImmunoPrecise Antibodies Ltd from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Benchmark
1calculated from analyst ratings
Analyst Ratings for ImmunoPrecise Antibodies
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/11/2025 | Buy Now | 358.72% | HC Wainwright & Co. | Swayampakula Ramakanth53% | $5 → $5 | Reiterates | Buy → Buy | Get Alert |
| 04/01/2025 | Buy Now | 175.23% | Benchmark | Robert Wasserman52% | $3 → $3 | Reiterates | Speculative Buy → Speculative Buy | Get Alert |
| 03/31/2025 | Buy Now | 358.72% | HC Wainwright & Co. | Swayampakula Ramakanth53% | $7 → $5 | Maintains | Buy | Get Alert |
| 03/14/2025 | Buy Now | 542.2% | HC Wainwright & Co. | Swayampakula Ramakanth53% | $7 → $7 | Reiterates | Buy → Buy | Get Alert |
| 12/11/2024 | Buy Now | 542.2% | HC Wainwright & Co. | Swayampakula Ramakanth53% | $9 → $7 | Maintains | Buy | Get Alert |
| 09/17/2024 | Buy Now | 725.69% | HC Wainwright & Co. | Swayampakula Ramakanth53% | $9 → $9 | Reiterates | Buy → Buy | Get Alert |
| 08/14/2024 | Buy Now | 175.23% | Benchmark | Robert Wasserman52% | $5 → $3 | Maintains | Speculative Buy | Get Alert |
| 07/30/2024 | Buy Now | 725.69% | HC Wainwright & Co. | Swayampakula Ramakanth53% | $9 → $9 | Reiterates | Buy → Buy | Get Alert |
| 03/15/2024 | Buy Now | 725.69% | HC Wainwright & Co. | Swayampakula Ramakanth53% | $9 → $9 | Reiterates | Buy → Buy | Get Alert |
| 03/15/2024 | Buy Now | 358.72% | Benchmark | Robert Wasserman52% | $5 → $5 | Reiterates | Speculative Buy → Speculative Buy | Get Alert |
| 09/18/2023 | Buy Now | 725.69% | HC Wainwright & Co. | Swayampakula Ramakanth53% | → $9 | Reiterates | Buy → Buy | Get Alert |
| 07/12/2023 | Buy Now | 725.69% | HC Wainwright & Co. | Swayampakula Ramakanth53% | → $9 | Reiterates | Buy → Buy | Get Alert |
| 07/11/2023 | Buy Now | 542.2% | Benchmark | Robert Wasserman52% | → $7 | Reiterates | Speculative Buy → Speculative Buy | Get Alert |
| 03/21/2023 | Buy Now | 542.2% | Benchmark | Robert Wasserman52% | $12 → $7 | Maintains | Speculative Buy | Get Alert |
| 03/17/2023 | Buy Now | 725.69% | HC Wainwright & Co. | Swayampakula Ramakanth53% | → $9 | Reiterates | → Buy | Get Alert |
| 12/02/2022 | Buy Now | 725.69% | HC Wainwright & Co. | Swayampakula Ramakanth53% | → $9 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for ImmunoPrecise Antibodies (IPA) stock?
The latest price target for ImmunoPrecise Antibodies (NASDAQ:IPA) was reported by HC Wainwright & Co. on April 11, 2025. The analyst firm set a price target for $5.00 expecting IPA to rise to within 12 months (a possible 358.72% upside). 8 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for ImmunoPrecise Antibodies (IPA)?
The latest analyst rating for ImmunoPrecise Antibodies (NASDAQ:IPA) was provided by HC Wainwright & Co., and ImmunoPrecise Antibodies reiterated their buy rating.
When was the last upgrade for ImmunoPrecise Antibodies (IPA)?
There is no last upgrade for ImmunoPrecise Antibodies
When was the last downgrade for ImmunoPrecise Antibodies (IPA)?
There is no last downgrade for ImmunoPrecise Antibodies.
When is the next analyst rating going to be posted or updated for ImmunoPrecise Antibodies (IPA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ImmunoPrecise Antibodies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ImmunoPrecise Antibodies was filed on April 11, 2025 so you should expect the next rating to be made available sometime around April 11, 2026.
Is the Analyst Rating ImmunoPrecise Antibodies (IPA) correct?
While ratings are subjective and will change, the latest ImmunoPrecise Antibodies (IPA) rating was a reiterated with a price target of $5.00 to $5.00. The current price ImmunoPrecise Antibodies (IPA) is trading at is $1.09, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
